TACSTD2 and cervical cancer: Trop2 is highly expressed in cervical cancer tissue (88.7%), and its overexpression correlates with International Federation of Gynecology and Obstetrics (FIGO) stage, histological grade, lymphatic metastasis, depth of interstitial invasion, and high expression of Ki-67 [99].